Explore more publications!

PurpleLab® Launches End-To-End Campaign Measurement With Self-Service Flexibility

WAYNE, PA, UNITED STATES, January 7, 2026 /EINPresswire.com/ -- PurpleLab®, a healthcare analytics company powering real‑world data through an infrastructure of more than 14 billion annual claims from a robust network of sources, 3 million+ healthcare practitioners, and 330 million+ U.S. patient lives, has launched a full end-to-end measurement solution suite — including self-service capabilities — through its HealthNexus® platform, standalone APIs, as well as custom measurement services. With the self-service model, advertisers can generate results at their convenience via API and auto-generated insight reports.

Healthcare marketers face slow and unclear campaign analytics, further complicated by stringent direct-to-consumer (DTC) regulations and fragmented identity signals. PurpleLab's new end-to-end measurement solution handles everything from ingestion of exposure data, to outcomes analysis and reporting — combined with giving users the ability to create their own measurement reports, on their terms. This enables advertisers to independently gain insight from results faster, helping maximize the value of every marketing dollar and ensuring campaigns are on track.

Built on de-identified health data, this measurement launch helps marketers understand how campaigns drive prescribing behavior so they can make more informed decisions, optimizing in-flight. By embedding real-world data directly into the campaign process, the platform turns measurement into a live feedback loop, facilitating mid and post-campaign analysis. Unlike point-solution vendors limited to media exposure or claims data, PurpleLab unifies both, bridging activation and outcomes across digital, TV, and programmatic environments.

With the launch, PurpleLab eliminates the need for external analytics cycles and replaces them with a direct, transparent workflow. Each report correlates outcomes, from audience match rates to control group logic, for deeper visibility into campaign performance. Additionally, an intuitive interface allows users to glean results without relying on an analyst, instantaneously.

“Advertisers shouldn’t have to choose between speed and trust,” said Scott Ronay, GM of Advertising at PurpleLab. “Our goal is to give teams confidence in how outcomes are derived, so they can act faster without sacrificing rigor or quality. As the industry moves toward real-time optimization, self-service measurement is becoming essential for marketers who need both agility and data integrity,” he added.

PurpleLab plans to continue the expansion of its measurement APIs, integrating HCP measurement enhancements and procedure insights, overlaid with agentic concept recommendations in 2026. All methodologies are HIPAA, IAB, and NAI compliant, ensuring privacy-first data practices.

About PurpleLab®
PurpleLab® is a healthcare analytics company dedicated to driving value-driven innovation across the healthcare continuum. Its no-code analytics platform, HealthNexus®, empowers life sciences, payers, providers, advertisers, and other healthcare stakeholders to develop real-world evidence (RWE), demonstrating the effectiveness of novel therapeutics or clinical strategies in saving lives and reducing costs.

The company is also a member of the Interactive Advertising Bureau (IAB), Network Advertising Initiative (NAI), adhering to the highest standards for responsible data collection and usage in digital advertising. Additionally, PurpleLab holds HITRUST certification, meeting the rigorous security and privacy requirements essential in healthcare data management.

For more information, visit purplelab.com.
###

Claudia Santos
Publicize
claudia@publicize.co

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions